Taurine Supplements and Coronary Microvascular Dysfunction
Current Guideline Position on Supplements
- The American Heart Association and American College of Cardiology guidelines explicitly state that nonprescription dietary supplements are not beneficial to reduce the risk of acute cardiovascular events in patients with chronic coronary disease 1, 2, 3
- The European Society of Cardiology guidelines recommend against vitamin or micronutrient supplementation to reduce the risk of diabetes or cardiovascular disease in patients with diabetes 4, 5, 6
- Dietary supplements have insufficient evidence to support their use for cardiovascular event reduction, and some supplements may even be harmful 7, 8
Clinical Recommendation for CMD Patients
- The American Heart Association and American College of Cardiology recommend prioritizing evidence-based interventions, including a Mediterranean diet rich in vegetables, fruits, legumes, nuts, whole grains, and lean protein 1, 2
- The American College of Cardiology emphasizes the importance of optimal medical management, including statins, antiplatelet therapy, blood pressure control, and diabetes management as indicated, although this specific point is from a less preferred source 9, 10
Important Caveats
- The absence of taurine from guideline recommendations reflects insufficient data rather than evidence of harm, distinguishing it from supplements like calcium or beta-carotene that have shown potential adverse effects 1, 3
- Patients should not substitute taurine supplementation for proven therapies like statins, antiplatelet agents, or lifestyle modifications, according to the American College of Cardiology, although this specific point is from a less preferred source 9, 10